Fingerprint
Dive into the research topics of 'Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer
Niamh McGivern, Aya El-Helali, Paul Mullan, Iain A McNeish, D Paul Harkin, Richard D Kennedy, Nuala McCabe
Research output: Contribution to journal › Article › peer-review
15
Citations
(Scopus)
249
Downloads
(Pure)